The Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Veterinary Active Pharmaceutical Ingredients Manufacturing Market?
The size of the Veterinary Active Pharmaceutical Ingredients Manufacturing market has seen a significant increase in recent years. It is projected to rise from $7.46 billion in 2024 to $8.05 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 7.9%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Veterinary Active Pharmaceutical Ingredients Manufacturing Industry?
The Veterinary Active Pharmaceutical Ingredients Manufacturing market is projected to grow to $11.19 billion by 2029, with a compound annual growth rate (CAGR) of 8.6%.
Download Your Free Sample of the 2025 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Veterinary Active Pharmaceutical Ingredients Manufacturing Market?
The key drivers in the veterinary active pharmaceutical ingredients manufacturing market are:
• Advancements in personalized veterinary medicine
• Globalization and market expansion in veterinary medicine
• Focus on regulatory compliance in this industry
• Rising importance and awareness of animal welfare
Global Market Segmentation: Identifying Major Veterinary Active Pharmaceutical Ingredients Manufacturing Industry Segments
The veterinary active pharmaceutical ingredients manufacturing market covered in this report is segmented –
1) By Product: Antiparasitic, Anti-Infectives, Vaccines, NSAIDs
2) By Service Type: In House, Contract Outsourcing
3) By Synthesis Type: Chemical Based API, Biological API, Highly Potent API
Pre-order the 2025 Veterinary Active Pharmaceutical Ingredients Manufacturing Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Veterinary Active Pharmaceutical Ingredients Manufacturing Market?
The key trends in the veterinary active pharmaceutical ingredients manufacturing market are:
• Personalized veterinary medicine is becoming an emerging trend.
• Outsourcing of API manufacturing is on the rise.
• A shift towards biotechnology-based APIs is becoming more prevalent.
• The advancements in digitalization and automation in manufacturing are shaping the market.
Who Are the Top Competitors & Leading Players in the Veterinary Active Pharmaceutical Ingredients Manufacturing Market?
Major companies in the veterinary active pharmaceutical ingredients manufacturing market are:
• Alivira Animal Health Limited
• Excel Industries Limited
• Ofichem Group B.V.
• Jiangsu Lingyun Pharmaceutical Co. Ltd.
• SUANFARMA S.A.
• NGL Fine
•Chem Limited
• FIS
• Fabbrica Italiana Sintetici S.p.A.
• Lupin Limited
• Aurobindo Pharma Limited
• Saneca Pharmaceuticals AS
• Neuland Laboratories Limited
• Divi's Laboratories Limited
• Zoetis Inc.
• Grupo Indukern S.L.
• Sequent Scientific Limited
• Chempro Pharma Private Limited
• AMGIS Lifescience Ltd.
• Huvepharma AD
• Vetpharma Animal Health S.L.
• Qilu Pharma Spain S.A.
• INDUKERN Chemie AG
• Chemopharma S.A.
• Norbrook Laboratories Limited
• Ceva Santé Animale S.A.
• Vetoquinol S.A.
• Virbac S.A.
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the veterinary active pharmaceutical ingredients manufacturing market in 2024
